FDA Guidance and New Drug Approvals

被引：2

|

作者：

Walker, Scot ^{[1
]}

机构：

[1] Prescribe Right LLC, 1602 Westglen Farms Dr, Wildwood, MO 63011 USA

来源：

HOSPITAL PHARMACY | 2018年 / 53卷 / 06期

关键词：

D O I：

10.1177/0018578718779355

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：360 / 362

页数：3

相关论文

共 50 条

[41] FDA new drug approvals in Q1 2023
Lisa Urquhart
Nature Reviews Drug Discovery, 2023, 22 : 346 - 346
[42] FDA new drug approvals in Q1 2018
Lisa Urquhart
Nature Reviews Drug Discovery, 2018, 17 : 309 - 309
[43] US FDA in Line with Japan, Europe for New Drug Approvals
Printz, Carrie
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2014, 7 (05): : 349 - 349
[44] FDA new drug approvals in Q1 2018
Urquhart, Lisa
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (05) : 309 - 309
[45] FDA new drug approvals in Q2 2023
Lisa Urquhart
Nature Reviews Drug Discovery, 2023, 22 : 614 - 614
[46] FDA new drug approvals in Q3 2021
Urquhart, Lisa
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (11) : 807 - 807
[47] FDA new drug approvals in Q2 2024
Verdin, Paul
NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (08) : 573 - 573
[48] FDA new drug approvals in Q3 2020
Urquhart, Lisa
NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (11) : 746 - 746
[49] FDA new drug approvals in Q2 2022
Lisa Urquhart
Nature Reviews Drug Discovery, 2022, 21 : 550 - 550
[50] FDA new drug approvals in Q2 2018
Urquhart, Lisa
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (08) : 536 - 537

← 1 2 3 4 5 →